[Beta-receptor blockers in ischemic heart disease: the pathophysiological and clinical aspects].
作者信息
Urbaszek W, Modersohn D
出版信息
Z Arztl Fortbild (Jena). 1979 Feb 1;73(3):101-6.
PMID:34938
Abstract
摘要
相似文献
1
[Beta-receptor blockers in ischemic heart disease: the pathophysiological and clinical aspects].
Z Arztl Fortbild (Jena). 1979 Feb 1;73(3):101-6.
2
Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts.β-肾上腺素能阻滞剂在缺血性心脏病中的多因素作用：当前概念
Circulation. 1983 Jun;67(6 Pt 2):I11-8.
3
4
[Intrinsic sympathomimetic activity with beta-receptor blockers. Significance for differential therapy (author's transl)].β受体阻滞剂的内在拟交感活性。对鉴别治疗的意义（作者译）
MMW Munch Med Wochenschr. 1982 Apr 16;124(15):377-80.
5
6
[Beta receptor blockers in coronary insufficiency and acute infarct. Pathophysiological bases].[β受体阻滞剂在冠状动脉供血不足和急性梗死中的应用。病理生理基础]
Dtsch Med Wochenschr. 1988 Apr 8;113(14):565-70. doi: 10.1055/s-2008-1067685.
7
[The therapy of chronic heart failure with beta-receptor blockers?].[β受体阻滞剂治疗慢性心力衰竭？]
Dtsch Med Wochenschr. 1990 May 25;115(21):825-31. doi: 10.1055/s-2008-1065088.
8
Verapamil in treatment of chronic stable angina.维拉帕米治疗慢性稳定型心绞痛。
Arch Intern Med. 1983 Jul;143(7):1407-15.
9
Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.变时性功能不全和使用β受体阻滞剂对男性运动平板试验的影响。
Am Heart J. 2001 Jul;142(1):136-41. doi: 10.1067/mhj.2001.115788.
Zotero 插件